Titan Biotech logo

Titan Biotech

TITANBIOTECHLTD NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹1,771 Cr
Volatility
Moderate
P/E Ratio
53
EBITDA
₹38.60 Cr
Return on Equity
11.91%
Debt to Equity
0.03
Book Value
₹43.94
EPS
₹30.36
52W High
₹555.65
52W Low
₹132.04

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company is expected to give good quarter

Weaknesses

2
  • Stock is trading at 9.95 times its book value
  • The company has delivered a poor sales growth of 7.71% over past five years.

Growth Rate

Revenue Growth
28.55% higher than 3Y
Net Income Growth
54.54% higher than 3Y
Cash Flow Change
-4.87% higher than 3Y
ROE
-32.83% lower than 3Y
ROCE
-32.62% higher than 3Y
EBITDA Margin (Avg.)
-0.33% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
35
43
46
40
43
40
38
35
46
54
57
49
59
Expenses
27
35
35
33
35
32
33
31
38
45
46
39
47
Operating Profit
8
9
11
7
8
8
5
5
9
9
11
10
12
OPM %
23%
20%
23%
18%
19%
19%
13%
13%
19%
17%
19%
20%
21%
Other Income
0
1
0
0
1
0
2
1
1
1
1
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
PBT
7
8
10
6
8
7
5
5
8
9
11
10
13
Tax %
24%
26%
26%
24%
24%
25%
26%
25%
24%
26%
26%
36%
26%
Net Profit
6
7
7
5
6
7
4
4
7
8
9
7
11
EPS in Rs
1.49
1.58
1.74
1.21
1.55
1.62
1.06
0.98
1.66
1.88
2.07
1.63
2.63
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
40
46
53
57
65
79
142
124
144
164
156
206
219
Expenses
36
42
47
50
56
66
96
92
114
130
131
168
176
Operating Profit
4
4
5
7
9
13
46
31
30
34
25
39
42
OPM %
10%
9%
10%
12%
14%
17%
32%
25%
21%
21%
16%
19%
19%
Other Income
0
1
0
0
1
1
0
1
2
2
4
5
6
Interest
1
1
1
2
2
2
2
1
1
1
1
1
1
Depreciation
1
1
1
1
2
2
2
2
3
3
4
5
5
PBT
2
3
3
4
6
10
43
29
28
32
24
38
43
Tax %
33%
34%
35%
35%
30%
25%
26%
25%
25%
25%
25%
28%
—
Net Profit
2
2
2
3
4
8
32
22
25
25
22
30
34
EPS in Rs
0.42
0.46
0.56
0.66
0.85
1.71
7.35
5.25
6.01
6.02
5.21
7.23
8.21
Div. Payout %
36%
33%
27%
23%
0%
12%
4%
6%
6%
7%
8%
7%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
8
8
8
8
8
8
8
8
8
8
Reserves
13
14
15
17
24
31
60
78
102
125
145
173
Borrowings
8
11
22
26
24
24
16
9
9
8
3
6
Other Liabilities
5
7
7
7
9
13
16
13
16
15
19
27
Total Liabilities
34
40
52
57
65
76
101
108
135
157
175
214
Fixed Assets
11
11
13
14
29
31
34
35
36
52
57
62
CWIP
1
5
9
13
0
0
0
4
13
3
2
2
Investments
0
0
0
0
0
0
0
4
15
28
33
60
Other Assets
21
24
30
30
36
45
67
65
70
74
83
90
Total Assets
34
40
52
57
65
76
101
108
135
157
175
214
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-2
5
0
2
5
6
19
22
21
21
20
30
Investing
-3
-5
-8
-6
-4
-2
-5
-16
-21
-20
-10
-34
Financing
3
2
9
0
0
-4
-11
-4
-2
-3
-8
0
Net Cash Flow
-2
2
1
-3
1
0
4
2
-2
-2
2
-4
Free Cash Flow
-3
0
-7
-4
1
8
14
8
8
12
12
21
CFO/OP
-28
143
21
43
74
62
65
93
97
85
103
101
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
58
47
44
49
52
54
46
48
53
42
44
40
Inventory Days
134
118
155
202
236
259
177
206
179
208
242
212
Days Payable
17
18
15
13
24
38
20
25
27
15
25
32
Cash Conversion Cycle
175
147
184
239
264
276
203
230
205
234
261
220
Working Capital Days
94
60
90
108
97
101
88
118
109
111
130
102
ROCE %
—
12%
12%
13%
15%
20%
58%
32%
27%
25%
17%
23%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Titan Biotech insights

59 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

DIIs0.01%Promot.55.78%Others16.19%Public28.02%As ofJun 2026

Documents

Frequently Asked Questions about Titan Biotech

What does Titan Biotech Ltd do?
Incorporated in 1992, Titan Biotech Ltd manufacturer and exporter of the Biological products[1]
Where is Titan Biotech Ltd (524717) listed?
Titan Biotech Ltd trades as TITANBIOTECHLTD on the NSE and under code 524717 on the BSE.
Which sector does Titan Biotech Ltd belong to?
Titan Biotech Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Titan Biotech Ltd?
Titan Biotech Ltd has a market capitalisation of ₹1,771 Cr, which places it in the Small Cap band.
What is the PE ratio of Titan Biotech Ltd?
Titan Biotech Ltd trades at a PE ratio of 53.00, on earnings per share of ₹30.36, against a book value of ₹43.94 per share.
What is the 52-week high and low of Titan Biotech Ltd?
Over the last 52 weeks Titan Biotech Ltd has traded between ₹132.04 and ₹555.65.
Does Titan Biotech Ltd pay dividends?
Titan Biotech Ltd has a dividend yield of 0.12%.
What is the Return on Equity (ROE) of Titan Biotech Ltd?
Titan Biotech Ltd reported a return on equity of 11.91%. Its debt-to-equity ratio is 0.03.

Company Information

Incorporated in 1992, Titan Biotech Ltd manufacturer and exporter of the Biological products[1]

Website titanbiotechltd.com
Face Value ₹ 2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524717.md for Titan Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List